See also this year's filing and all EDGAR filings for this company.
PDF Report 0001438533_2014_Travere_Therapeutics_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.3686041804257765, 'aggregate_val': 33823509, 'exp_sum': 14279933, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 16888064, 'ResearchAndDevelopmentExpense': 7084009, 'remainder_Expenses': -9692140}} |
Graph
Absolute values for 0001438533, Travere Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,501,244 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 127,427 |
| 3 | remainder_Assets | 12,870,208 |
| 4 | LiabilitiesCurrent | 35,209,878 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,600,899 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,888,064 |
| 9 | ResearchAndDevelopmentExpense | 7,084,009 |
| 10 | remainder_Expenses | 9,851,436 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -33,747,734 |
| 13 | remainder_ComprehensiveNetIncome | -109,987 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,498,879 |
| 1 | Liabilities | 38,810,777 |
| 2 | Expenses | 33,823,509 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -18,311,898 |
| 5 | NetIncome | -67,571,243 |
| 6 | ComprehensiveNetIncome | -67,626,236 |
| 7 | BaseVar | 63,495,443 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.63 |
| 9 | EconomicCapitalRatio | 0.493 |
Edgar->Model Mapping
Feature Distribution
